We will discover the next generation of precision medicines by targeting the molecular machines that underlie human disease.
Investors 1
Mentions in press and media 4
| Date | Title | Description | Source |
| 12.05.2022 | Inside SoftBank’s side letter with Better CEO Vishal Garg | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 15.04.2020 | Moma Therapeutics aims at molecular machines with $86M raise | Moma Therapeutics wants to crack a new type of drug target wide open. The company snagged $86 millio... | fiercebiot... |
| 15.04.2020 | The newest, $86M Third Rock startup chases the tiny biol... | It took 23 years from the isolation of the gene for cystic fibrosis to the approval of the fir... | endpts.com... |
| 15.04.2020 | Moma Therapeutics aims at molecular machines with $86M raise | Moma Therapeutics wants to crack a new type of drug target wide open. The company snagged $86 millio... | fiercebiot... |